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MALAT-1, a long non-coding RNA, is associated with metastasis, but its role in the metastatic process
remains unknown. Here, we show that short-interfering RNA-mediated MALAT-1 silencing impaired
in vitro cell motility of lung cancer cells and inﬂuenced the expression of numerous genes. In these
genes, knockdown of any one of CTHRC1, CCT4, HMMR, or ROD1 clearly inhibited cell migration. In
MALAT-1 knockdown cells, pre-mRNA levels were decreased in some but not all genes. Thus, our
ﬁndings suggest that MALAT-1 is a novel class of non-coding RNA that promotes cell motility
through transcriptional and post-transcriptional regulation of motility related gene expression.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Metastasis is the major cause of mortality in patients with solid
tumors [1]. Changes in cell characteristics, such as cell adhesion,
motility, expression of matrix metalloproteases and proliferation,
are major determinants of the development of metastatic cancer
cells [2]. A considerable number of protein-coding genes in a vari-
ety of experimental systems have been shown to affect metastatic
capacity, and several mechanisms altering the ability of tumor cells
to metastasize have been identiﬁed. However, our understanding
of the molecular determinants of metastasis remains limited.
The mammalian genome appears to have fewer protein-
coding genes than previously anticipated, and the numbers of pro-
tein-coding genes do not proportionally increase with genome
complexity [3]. Recent large-scale transcriptome analyses have re-
vealed that a large number of transcripts with low protein-coding
potential, known as non-coding RNAs (ncRNAs), are highly
transcribed from most genomes, including intergenic regions [4].
The ncRNAs are classiﬁed into small ncRNAs (20–200 nt), such as
microRNAs, and long ncRNAs (>200 nt). Recently, numerouschemical Societies. Published by E
er, University of Tokyo, 2-11-
1 3 5841 3049.
mitsu).microRNAs have been implicated in certain biological processes,
namely, the neoplastic transformation and metastatic processes,
establishing their biological importance [5]. Moreover, recent stud-
ies have also revealed that a large number of long ncRNAs exhibit
tissue-speciﬁc, stage-speciﬁc, or disease-related expression pat-
terns. These ncRNAs are attractive candidates as regulators of bio-
logical processes and disease progression. However, the proven
physiological functions of long ncRNAs are limited. Some examples
are XIST, Air and MEN e/b, which are involved in regulation of gen-
ome organization and gene expression [6–8].
Metastasis-associated lung adenocarcinoma transcript 1 (MA-
LAT-1)/nuclear enriched abundant transcript 2 (NEAT2) was origi-
nally identiﬁed as a long ncRNA, exhibiting signiﬁcant expression
in individuals at high risk for metastasis of non-small cell lung tu-
mors [9]. MALAT-1 has been shown to be over-expressed in many
solid tumors [10]. After transcription, nascent MALAT-1 is pro-
cessed into a 50-long transcript and a 30-short tRNA-like transcript
by RNase P cleavage [11]. The long form of MALAT-1 is subse-
quently localized to nuclear speckles [12]. Several lines of evidence
suggest that nuclear speckles function as storage/assembly/modiﬁ-
cation compartments that supply splicing and transcription factors
to active transcription sites [13], or that they act as hubs facilitat-
ing the efﬁciency and integration of distinct steps in gene expres-
sion, ranging from transcription to mRNA export [14].lsevier B.V. All rights reserved.
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Fig. 1. Impaired cell motility of MALAT-1 knockdown (KD) cells in vitro. (A) Silencing of MALAT-1 by siRNA in A549 cells. The expression level of each indicated RNA was
determined by Northern blot hybridization. (B) Wound healing assays demonstrated reduced migration of MALAT-1 KD A549 cells following 21 h incubation. Values for the
wounded area ﬁlled through cell migration (%) represent the means ± standard deviation (S.D.) of four wells obtained from independent experiments. Signiﬁcant differences
between control cells and MALAT-1 KD cells were observed (P < 0.01, Student’s t-test). (C) Transwell assays demonstrated impaired migration of MALAT-1 KD A549 cells.
Migration rates (migrated cells/total cells) in cells transfected with MALAT-1 siRNA compared with control cells are shown. Values represent the means ± S.D. of three
independent experiments. **Statistically signiﬁcant differences (P < 0.01) between control and MALAT-1 KD cells were determined by Student’s t-test. (D) Viability of control
and MALAT-1 KD cells were determined with a cell counting Kit-8 (Dojindo). Values represent means ± S.D. obtained from three independent experiments. No statistically
signiﬁcant differences between MALAT-1 KD and control cells were observed.
4576 K. Tano et al. / FEBS Letters 584 (2010) 4575–4580The high correlation between enhanced MALAT-1 expression
and progression of metastasis prompted us to hypothesize that
MALAT-1 contributes to cellular events underlying metastatic
transformation in cancer cells, such as enhanced cell migration or
facilitated proliferation. Here, we report that the RNA interference
(RNAi)-mediated silencing of MALAT-1 impaired the in vitromigra-
tion of a lung adenocarcinoma cells. Moreover, we propose that
MALAT-1 facilitates cell motility through the concomitant regula-
tion of expression of motility-related genes – collagen triple helix
repeat containing 1 (CTHRC1), chaperonin-containing tailless com-plex polypeptide, subunit 4 (CCT4), hyaluronan-mediated motility
receptor (HMMR) or regulator of differentiation 1 (ROD1)- via tran-
scriptional and/or post-transcriptional regulation.
2. Materials and methods
2.1. Cell migration assay
A549 cells were grown at 37 C, 5% CO2 in Dulbecco’s Modiﬁed
Eagle’s Medium, supplemented with 10% fetal bovine serum (FBS)
K. Tano et al. / FEBS Letters 584 (2010) 4575–4580 4577and penicillin/streptomycin. Wound-healing assay was performed
as previously described [15]. Brieﬂy, the cell layer that reached
conﬂuence was scratched by a 200 ll pipette tip, and cultured at
37 C. The average extent of wound closure was quantiﬁed. The
percent of wounded area ﬁlled through cell migration was then
calculated as follows: [(mean wound width-mean remaining
width)/mean wound width]  100 (%). Transwell assay was per-
formed as follows. Cells (2  104 cells in 200 ll medium with 1%
FBS) were added to upper transwells (8.0-lm pore, Falcon). A med-
ium containing 1% FBS (700 ll) was added to the lower wells. After
incubation for 24 h, cells were ﬁxed and stained, and the number of
total cells (cells on both sides of the ﬁlter) was counted. After non-
migratory cells were scraped from the upper part of the ﬁlter, cells
migrated to the lower wells through pores were counted. Cells
were counted on four random ﬁelds per well.
2.2. Quantitative real time reverse transcription-PCR (qRT-PCR)
Total RNA prepared from cells using Trizol (Invitrogen) was re-
verse transcribed to produce cDNA with the Quantitect Reverse
Transcription Kit (Qiagen). For quantitative analysis of mRNA level
and pre-mRNA level, aliquots of cDNA were subjected to Quantita-
tive real-time PCR using primer sets listed in Supplementary Tables
S3 and S4 and the SYBR premix II reaction mixture (Takara Bio)
according to the manufacturer’s instructions. Each value was nor-
malized to the expression level of glyceraldehyde 3-phosphate
dehydrogenase mRNA.
3. Results and discussion
We examined the effect of MALAT-1 depletion (Fig. 1A, 70–80%
reduction compared to control) on cell migration, proliferation,
expression of MMP2 and 9, adhesion, or anchorage-independent
cell growth in the human lung adenocarcinoma cell line, A549.
An in vitro wound-healing assay revealed that MALAT-1 silencing
impaired the in vitro cell motility of the A549 cells compared to
appropriate control cells transfected with control siRNA (Fig. 1B).
A similar result was obtained with another MALAT-1 siRNA target-
ing a different sequence of MALAT-1 (data not shown), providing
further support for the notion that MALAT-1 silencing impairs cell
migration. We also conﬁrmed this observation using a transwell
migration assay. As shown in Fig. 1C, migration rates of MALAT-1
knockdown (KD) cells were signiﬁcantly reduced compared with
those of control cells. In contrast, MALAT-1 silencing had no effect0 
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Fig. 2. Altered gene expression in MALAT-1 KD cells. Values represent the
means ± S.D. obtained from three independent experiments. ***Statistically signif-
icant differences (P < 0.001) between control and MALAT-1 KD cells were deter-
mined by the Student’s t-test.on cell proliferation (Fig. 1D), expression of MMP2 and 9, adhesion
or anchorage-independent cell growth (data not shown). These re-
sults imply a potential role for MALAT-1 in cell motility of lung
adenocarcinoma without affecting other functions, such as
proliferation.
MALAT-1 was reported to be an ncRNA localized to nuclear
speckles [12]. Therefore, we hypothesized that the function of MA-
LAT-1 is associated with the role of nuclear speckles, namely pre-
mRNAmetabolism or transcriptional regulation. Based on this idea,
we surveyed the differentially expressed genes between MALAT-1
KD and control cells by DNA microarray analysis. Numerous genes
showing signiﬁcant differential expression were identiﬁed in the
microarray analysis in two independent MALAT-1 KD cell lines
transfected with different siRNAs (Supplementary Fig. S1). The
qRT-PCR analysis was also performed to conﬁrm the expression le-
vel of differential expressed genes (Fig. 2 and Table S2). The down-
regulated genes in MALAT-1 KD cells included genes previously
implicated in extracellular matrix and cytoskeleton regulation,
such as LAYN, HMMR, SLC26A2, CCT4, CTHRC1 and FHL1.
To clarify the possible function of down-regulated genes in the
motility of A549 cells, we investigated the effects of siRNA-medi-
ated reduction of these genes on cell motility. Silencing of CTHRC1,
CCT4, HMMR or ROD1 also signiﬁcantly impaired the in vitro cell
migration activity of A549 cells (Fig. 3). The siRNAs targeting
different sequences of these genes also impaired cell migration
(Supplementary Fig. S2), ruling out the possibility that an off-target
effect of siRNA caused the impaired migration. These results sug-
gest that the silencing of MALAT-1 reduced cell motility through
concomitant down-regulation of CTHRC1, CCT4, HMMR and ROD1.
CTHRC1 is a secreted protein that inhibits collagen expression
and promotes cell migration [17]. CCT4 is an important component
of the chaperonin-containing tailless complex polypeptide (CCT), a
cytosolic molecular chaperonin involved in folding tubulin, actin
and other cytosolic proteins [18]. Although CCT4 is not known to
promote cell migration, it is reasonable to assume that CCT4 inﬂu-
ences migration by affecting the formation of the cytoskeleton
[19]. HMMR is reported to promote cell migration [20]. ROD1 is
an RNA-binding protein affecting splicing [21]. To the best of our
knowledge, no report has provided evidence that ROD1 inﬂuences
cell motility.
To further elucidate the MALAT-1-mediated regulation of gene
expression, we measured the levels of pre-mRNAs for genes that
were down-regulated in MALAT-1 KD cells. In the case of AIM1,
LAYN and HMMR, both pre-mRNA levels and mature mRNA levels
were proportionally reduced (compare Fig. 4A with Fig. 2). The
reduction in the levels of pre-mRNAs for these genes could be
attributed to the rapid degradation of pre-mRNA. Therefore, we
measured the half-lives of pre-mRNAs following the addition of
the transcription inhibitor 5,6-dichloro-1-D-ribofuranosylbenzimi-
dazole (DRB). The turnover rates of these pre-mRNAs in MALAT-1
KD cells were not changed (Fig. 4B), implying that the rapid degra-
dation of pre-mRNAs cannot explain for the reduced pre-mRNA
levels. Our results suggest that MALAT-1 inﬂuences expression of
these genes at the transcriptional level. In contrast, the pre-mRNA
levels for six genes, including CTHRC1, CCT4 and ROD1, were not re-
duced in MALAT-1 KD cells, whereas the mature mRNA levels were
signiﬁcantly reduced by the silencing of MALAT-1 (compare Fig. 4A
with Fig. 2), suggesting that MALAT-1 silencing inﬂuences expres-
sion of these genes at a post-transcriptional level.
It is our conclusion that MALAT-1, retained in the nucleus, is a
novel class of ncRNA that positively regulates cell motility through
the concomitant regulation of motility-related genes such as
CTHRC1, CCT4, HMMR and ROD1 via transcriptional and/or post-
transcriptional regulation. Two relevant studies have recently been
published. One study suggested that MALAT-1 is involved in tro-
phoblast invasion during the development of advanced invasive
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Fig. 3. In vitro motility of cells transfected with siRNAs against the indicated transcripts, expression of which is altered in MALAT-1 KD cells. Transwell assays demonstrated
the reduced cell motility of A549 cells transfected with the indicated siRNA1. Migration rates (migrated cells/total cells) in cells transfected with siRNA1 against the indicated
transcripts (Table S1) were compared with those in control cells (Control siRNA1-transfected cells). Values represent the means ± S.D. obtained from three independent
experiments. Statistically signiﬁcant differences (**P < 0.01, ***P < 0.001) between KD and control cells were determined by the Student’s t-test.
4578 K. Tano et al. / FEBS Letters 584 (2010) 4575–4580placentation, but did not describe the molecular mechanism
underlying this action of MALAT-1 [22]. The other study suggested
that silencing of MALAT-1 suppresses the migration of CaSki hu-man cervical cancer cells [23]. Although the authors reported that
MALAT-1 inﬂuenced the expression of apoptosis-related genes,
they could not identify the link between altered cell migration
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K. Tano et al. / FEBS Letters 584 (2010) 4575–4580 4579and altered gene expression [23]. In light of our results, and the
ﬁndings in these two recent reports [22,23], we propose that MA-
LAT-1 facilitates cell motility through the concomitant regulation
of expression of motility-related genes via transcriptional and/or
post-transcriptional regulation.
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